Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 0 to 18 years~* solid malignancy~* Lansky score \>70%~* more than 17 days since the beginning of the last chemotherapy cycle~* absolute neutrophil count (ANC) greater than 1×109/l~* no administration of any hematopoietic growth factor in the previous 8 days~Exclusion Criteria:~* clinical or biological conditions precluding the mobilization or collection procedure

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).